NovaBay Pharmaceuticals to Present at Rodman & Renshaw Global Investment Conference

by Business Wire • 2015/09/03 • 0 Comments

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company commercializing and developing novel topical non-antibiotic antimicrobial products for the global eye care market, announces that President and CEO Ron Najafi, Ph.D., will present at the Rodman & Renshaw 17th Annual Global Investment Conference on Thursday, September 10, 2015 at 3:25 p.m. Eastern time (12:25 p.m. Pacific time). The conference is being held at the St. Regis Hotel

← Diabetic retinopathy screening for children with type 1 diabetes should start later

ACADIA Pharmaceuticals Appoints Steve Davis as Chief Executive Officer →

Post navigation